About Incline Therapeutics
Incline Therapeutics is a company based in Redwood City (United States) founded in 2009 was acquired by The Medicines Company in December 2012.. Incline Therapeutics has raised $43.94 million across 3 funding rounds from investors including Frazier Healthcare Partners, The Medicines Company and 5AM Ventures. Incline Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Incline Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43.94 M (USD)
in 3 rounds
-
Latest Funding Round
$21.5 M (USD), Series B
Sep 13, 2011
-
Investors
Frazier Healthcare Partners
& 6 more
-
Employee Count
Employee Count
-
Acquired by
The Medicines Company
(Dec 12, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Incline Therapeutics
Incline Therapeutics has successfully raised a total of $43.94M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $21.5 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $21.5M
-
First Round
First Round
(19 Jan 2010)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2011 | Amount | Series B - Incline Therapeutics | Valuation |
investors |
|
| Jun, 2010 | Amount | Series B - Incline Therapeutics | Valuation | Frazier Healthcare Partners , 5AM Ventures |
|
| Jan, 2010 | Amount | Seed - Incline Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Incline Therapeutics
Incline Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Frazier Healthcare Partners, The Medicines Company and 5AM Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and energy companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Incline Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Incline Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Incline Therapeutics Comparisons
Competitors of Incline Therapeutics
Incline Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Incline Therapeutics
When was Incline Therapeutics founded?
Incline Therapeutics was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is Incline Therapeutics located?
Incline Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Incline Therapeutics a funded company?
Incline Therapeutics is a funded company, having raised a total of $43.94M across 3 funding rounds to date. The company's 1st funding round was a Seed of $440K, raised on Jan 19, 2010.
What does Incline Therapeutics do?
Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.
Who are the top competitors of Incline Therapeutics?
Incline Therapeutics's top competitors include Flexion Therapeutics, scPharmaceuticals and Cara Therapeutics.
Who are Incline Therapeutics's investors?
Incline Therapeutics has 7 investors. Key investors include Frazier Healthcare Partners, The Medicines Company, 5AM Ventures, Technology Partners, and Adams Street Partners.